Triller Group Inc. Receives Nasdaq Delisting Notice Over MVLS Shortfall

What Happened

• Triller Group Inc. announced that on August 27, 2026 it received a notice from the Nasdaq Listing Qualifications Staff stating the company no longer meets Nasdaq Listing Rule 5550(b)(2) because its market value of listed securities (MVLS) for the 30 business days ended August 25, 2026 was below the $35.0 million minimum. Nasdaq’s notice could lead to delisting of the company’s securities.
• The company was given seven calendar days to submit a plan to regain compliance; Triller said it will timely submit a plan for review by the Nasdaq Hearings Panel. The filing notes prior Panel action: although Triller previously met listing criteria (including the $1.00 bid-price requirement), the Panel stated it would retain jurisdiction through October 14, 2026 and that failure to meet any requirement by that date could prompt delisting without the typical cure period.
• Triller’s counsel sent a letter on August 26, 2026 disputing the Panel’s authority to retain jurisdiction under Nasdaq Listing Rule 5815(c)(1)(A) and raising concerns under Section 6(b)(7) of the Securities Exchange Act of 1934. The company is evaluating options including further engagement with Nasdaq and potential judicial relief.

Key Details

• Date of Nasdaq notice: August 27, 2026 (MVLS measured through August 25, 2026).
• Nasdaq rule cited: Listing Rule 5550(b)(2) — minimum MVLS required: $35 million.
• Company deadline: seven calendar days to submit a compliance plan to the Nasdaq Hearings Panel.
• Panel jurisdiction dispute: company sent counsel letter on August 26, 2026 and may seek court review if unresolved.

Why It Matters

• A continued failure to meet the $35M MVLS requirement could result in Nasdaq delisting, which would materially affect liquidity and trading for shareholders.
• The company’s dispute with the Hearings Panel over continued jurisdiction affects the process and timing for addressing any future deficiencies; Triller may not receive the same cure periods other issuers get if the Panel’s approach stands.
• Investors should watch for the company’s submitted compliance plan, any Panel decisions, and whether Triller pursues judicial action, as these next steps will determine whether the shares remain listed on Nasdaq.